Nuclear targeting defect of SMN lacking the C-terminus in a mouse model of spinal muscular atrophyFRUGIER, T; TIZIANO, F. D; CIFUENTES-DIAZ, C et al.Human molecular genetics (Print). 2000, Vol 9, Num 5, pp 849-858, issn 0964-6906Article

The 312N variant of the luteinizing hormone/choriogonadotropin receptor gene (LHCGR) confers up to 2·7-fold increased risk of polycystic ovary syndrome in a Sardinian populationCAPALBO, A; SAGNELLA, F; CIARDULLI, A et al.Clinical endocrinology (Oxford. Print). 2012, Vol 77, Num 1, pp 113-119, issn 0300-0664, 7 p.Article

Apolipoprotein E ε4 allele differentiates the clinical response to donepezil in Alzheimer's diseaseBIZZARRO, A; MARRA, C; ACCIARRI, A et al.Dementia and geriatric cognitive disorders. 2005, Vol 20, Num 4, pp 254-261, issn 1420-8008, 8 p.Article

The APOE-491 A/T promoter polymorphism effect on cognitive profile of Alzheimer's patientsVALENZA, A; BIZZARRO, A; MARRA, C et al.Neuroscience letters. 2010, Vol 472, Num 3, pp 199-203, issn 0304-3940, 5 p.Article

Salbutamol increases SMN mRNA and protein levels in spinal muscular atrophy cellsANGELOZZI, C; BORGO, F; TIZIANO, F. D et al.Journal of medical genetics. 2008, Vol 45, Num 1, pp 29-31, issn 0022-2593, 3 p.Article

Randomized, double-blind, placebo-controlled trial of phenylbutyrate in spinal muscular atrophyMERCURI, E; BERTINI, E; CINI, C et al.Neurology. 2007, Vol 68, Num 1, pp 51-55, issn 0028-3878, 5 p.Article